InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,104.13
(
1.10%
)
US TECH 100
17,205.20
(
1.34%
)
Dow Jones
38,289.76
(
0.54%
)
Brent Oil
88.23
(
0.09%
)
Bitcoin
64,711.77
(
0.34%
)
Post# of 216
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

TREND1

Send PM Follow Ignore
Followers 417
Posts 52354
Boards Moderated 13
Alias Born 12/16/2001

TREND1

Member Level

Re: None

Monday, 07/17/2017 6:08:48 PM

Monday, July 17, 2017 6:08:48 PM

Post# of 216
7/17 Valeant: At Worst, A Good Catalyst Play

•Valeant Pharmaceuticals expects the FDA decision for Latanoprostene Bunod in August.

•For new investors, this may be an opportunity for some quick gains.

•For old hands suffering from the stock’s two-year depressive run, these are signs of better times.



https://seekingalpha.com/article/4088234-valeant-worst-good-catalyst-play?auth_param=1vat:1cmq954:a55cc18f6c84b7733efeb41778142367&uprof=51

MAIN BOARD http://investorshub.advfn.com/TRADING-3X-TNA-TQQQ-SPXL-RUS-2000-FUTURES-12981/

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up